These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
321 related articles for article (PubMed ID: 9798342)
41. Topical CpG enhances the response of murine malignant melanoma to dacarbazine. Najar HM; Dutz JP J Invest Dermatol; 2008 Sep; 128(9):2204-10. PubMed ID: 18368132 [TBL] [Abstract][Full Text] [Related]
42. Long-term favorable response to interferon beta-1b is linked to cytokine deviation toward the Th2 and Tc2 sides in Japanese patients with multiple sclerosis. Mei FJ; Osoegawa M; Ochi H; Minohara M; Nan S; Murai H; Ishizu T; Taniwaki T; Kira J J Neurol Sci; 2006 Jul; 246(1-2):71-7. PubMed ID: 16581087 [TBL] [Abstract][Full Text] [Related]
43. Effect of chemotherapy and immunotherapy on tumor-specific immunity in melanoma. Mitchell MS; Mokyr MB; Davis JM J Clin Invest; 1977 Jun; 59(6):1017-26. PubMed ID: 863999 [TBL] [Abstract][Full Text] [Related]
44. Natural killer receptors on CD8 T cells and natural killer cells from different HLA-C phenotypes in melanoma patients. Campillo JA; Martínez-Escribano JA; Moya-Quiles MR; Marín LA; Muro M; Guerra N; Parrado A; Campos M; Frías JF; Minguela A; García-Alonso AM; Alvarez-López MR Clin Cancer Res; 2006 Aug; 12(16):4822-31. PubMed ID: 16914567 [TBL] [Abstract][Full Text] [Related]
45. Primary malignant melanoma of the esophagus treated by esophagectomy and systemic chemotherapy. Matsutani T; Onda M; Miyashita M; Hagiwara N; Akiya Y; Takubo K; Yamashita K; Sasajima K Dis Esophagus; 2001; 14(3-4):241-4. PubMed ID: 11869329 [TBL] [Abstract][Full Text] [Related]
46. Anorectal melanoma: successful treatment by surgical excision and combination chemoimmunotherapy. Terada R; Ito S; Kobayashi M; Akama F; Tsujimura M; Ooe H Hepatogastroenterology; 2002; 49(48):1545-8. PubMed ID: 12397731 [TBL] [Abstract][Full Text] [Related]
47. [Improvement of host-immunity by adjuvant therapy with juzen-taiho-to for patients with brain tumors]. Miyagami M; Katayama Y No Shinkei Geka; 2003 Apr; 31(4):401-9. PubMed ID: 12704821 [TBL] [Abstract][Full Text] [Related]
48. Unique functional status of natural killer cells in metastatic stage IV melanoma patients and its modulation by chemotherapy. Fregni G; Perier A; Pittari G; Jacobelli S; Sastre X; Gervois N; Allard M; Bercovici N; Avril MF; Caignard A Clin Cancer Res; 2011 May; 17(9):2628-37. PubMed ID: 21224372 [TBL] [Abstract][Full Text] [Related]
49. Parameters of interferon action: II. Immunological effects of recombinant leukocyte interferon (IFN-alpha 2) in phase I-II trials. Ernstoff MS; Fusi S; Kirkwood JM J Biol Response Mod; 1983; 2(6):540-7. PubMed ID: 6607324 [TBL] [Abstract][Full Text] [Related]
51. Chemoimmunotherapy with bleomycin, vincristine, lomustine, dacarbazine (BOLD), and human leukocyte interferon for metastatic uveal melanoma. Pyrhönen S; Hahka-Kemppinen M; Muhonen T; Nikkanen V; Eskelin S; Summanen P; Tarkkanen A; Kivelä T Cancer; 2002 Dec; 95(11):2366-72. PubMed ID: 12436444 [TBL] [Abstract][Full Text] [Related]
52. [Malignant melanoma of the alimentary tract]. Nakamura T; Ide H Gan To Kagaku Ryoho; 2003 May; 30(5):619-25. PubMed ID: 12795092 [TBL] [Abstract][Full Text] [Related]
53. Multiparametric flow cytometric analysis of signal transducer and activator of transcription 5 phosphorylation in immune cell subsets in vitro and following interleukin-2 immunotherapy. Varker KA; Kondadasula SV; Go MR; Lesinski GB; Ghosh-Berkebile R; Lehman A; Monk JP; Olencki T; Kendra K; Carson WE Clin Cancer Res; 2006 Oct; 12(19):5850-8. PubMed ID: 17020993 [TBL] [Abstract][Full Text] [Related]
54. Changes in T and B lymphocyte subpopulations before, during and after chemotherapy for malignant melanoma. Bernengo MG; Lisa F; Meregalli M; Doveil GC Int J Tissue React; 1984; 6(6):505-11. PubMed ID: 6335712 [TBL] [Abstract][Full Text] [Related]
55. Mesenchymal stem cells: potential precursors for tumor stroma and targeted-delivery vehicles for anticancer agents. Studeny M; Marini FC; Dembinski JL; Zompetta C; Cabreira-Hansen M; Bekele BN; Champlin RE; Andreeff M J Natl Cancer Inst; 2004 Nov; 96(21):1593-603. PubMed ID: 15523088 [TBL] [Abstract][Full Text] [Related]
56. Complex combination biochemotherapy regimen in advanced metastatic melanoma in a non-intensive care unit: toxicity or benefit? Hofmann MA; Sterry W; Trefzer U Jpn J Clin Oncol; 2007 Mar; 37(3):224-9. PubMed ID: 17472972 [TBL] [Abstract][Full Text] [Related]
57. [Skin cancer melanoma]. Ishihara K Gan To Kagaku Ryoho; 1999 Jun; 26 Suppl 1():173-84. PubMed ID: 10410672 [TBL] [Abstract][Full Text] [Related]
58. Long-term survival benefit after adjuvant treatment of cutaneous melanoma with dacarbazine and low dose natural interferon alpha: A controlled, randomised multicentre trial. Stadler R; Luger T; Bieber T; Köhler U; Linse R; Technau K; Schubert R; Schroth K; Vakilzadeh F; Volkenandt M; Gollnick H; Von Eick H; Thoren F; Strannegård O Acta Oncol; 2006; 45(4):389-99. PubMed ID: 16760174 [TBL] [Abstract][Full Text] [Related]
59. Cytotoxic antimelanoma drugs suppress the activation of M2 macrophages. Fujimura T; Kakizaki A; Kambayashi Y; Sato Y; Tanita K; Lyu C; Furudate S; Aiba S Exp Dermatol; 2018 Jan; 27(1):64-70. PubMed ID: 28833504 [TBL] [Abstract][Full Text] [Related]
60. [Chemotherapy for the treatment of angiosarcoma]. Masuzawa M Gan To Kagaku Ryoho; 1993 Aug; 20(10):1314-9. PubMed ID: 8346929 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]